Third Harmonic Bio, Inc. (THRD)

NASDAQ: THRD · IEX Real-Time Price · USD
19.35
+0.23 (1.20%)
Oct 6, 2022 9:33 AM EDT - Market open

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020
Selling, General & Admin
3.261.17
Research & Development
15.759.95
Operating Expenses
1911.12
Operating Income
-19-11.12
Other Expense / Income
10.611.69
Pretax Income
-29.61-12.81
Net Income
-29.61-12.81
Net Income Common
-29.61-12.81
Shares Outstanding (Basic)
98
Shares Outstanding (Diluted)
98
Shares Change
10.23%-
EPS (Basic)
-3.24-1.55
EPS (Diluted)
-3.24-1.55
Free Cash Flow Per Share
-1.72-1.11
EBITDA
-29.61-12.81
EBIT
-29.61-12.81
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).